VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1384457
Sex: F
Age:
State: CA

Vax Date: 02/25/2021
Onset Date: 02/26/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Dull continuous pain in left arm where shot was administered; Painful to lift arm above head; too weak to hold things.; Felt pain in veins in arm and muscle, down to my finger; Felt pain in veins in arm and muscle, down to my finger; Felt pain in veins in arm and muscle, down to my finger; Some chest pain on the left side; This is a spontaneous report from a contactable consumer reported for herself. A 27-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE Solution for injection Batch/Lot number was not reported) via an unspecified route of administration in arm left on 25Feb2021 as 1st dose, single dose for COVID-19 immunisation. Medical history included as none. Concomitant medications included sertraline (SERTRALINE) 100 mg taken for an unspecified indication, start and stop date were not reported in two weeks. No other vaccine in four weeks. No covid prior vaccination and tested covid post vaccination known allergies were none. On 26Feb2021 12:00 AM, patient experienced dull continuous pain in left arm where shot was administered, painful to lift arm above head and too weak to hold things, felt pain in veins in arm and muscle, down to my fingers. Some chest pain on the left side happened a few days later. The patient underwent lab tests and procedures which included sars-cov-2 test resulted as negative on an unspecified date. Covid test type post vaccination was nasal swab. No treatment received. The clinical outcome of the event was resolving. No follow-up attempts are possible; information about lot/batch number cannot been obtained.

Other Meds: SERTRALINE

Current Illness:

ID: 1384458
Sex: F
Age:
State: NJ

Vax Date: 03/09/2021
Onset Date: 03/10/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Transient diarrhea; This is a spontaneous report from a contactable consumer (patient, self-reporting). A 85-years-old female (not pregnant) patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no and expiration date was not reported), via unspecified route of administration in left arm on 09Mar2021 at 12:30 as 1st dose, single for COVID-19 immunization (at the age of 85-years). Medical history included hypertension from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took bactrim and experienced drug hypersensitivity. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, she has not been tested for COVID-19. On 10Mar2021 at 10:00, the patient experienced transient diarrhea. The patient did not receive any treatment for the events. The clinical outcome for the event was recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1384459
Sex: F
Age:
State: VA

Vax Date: 02/15/2021
Onset Date:
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: The first shot caused soreness in my arm where the injection was made; a rash on both inner thighs/rash on the left side of my face; This is a spontaneous report from a contactable consumer or other non hcp. A 72-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 15Feb2021 14:00 (Batch/Lot Number: EN6201) as 1st dose, single dose for covid-19 immunisation. Medical history included high blood pressure, cholesterol, diverticulosis (it is not active at this time). Concomitant medication included AMLODIPINE and ROSUVASTATIN. The patient was not tested positive prior vaccination. The patient did not have covid prior vaccination. The patient did not have known allergies. The patient experienced the first shot caused soreness in my arm where the injection was made and a rash on both inner thighs/rash on the left side of my face. It was reported that, the first shot caused soreness in patient arm where the injection was made, which went away after about three days. After about 10 days, patient developed a rash on both inner thighs. It cleared up in about 3 days. Patient also had a rash on the left side of my face about the same time. Patient took prescription medicine for high blood pressure and cholesterol. Patient had diverticulosis, but it was not active at this time. No treatment was received. The outcome for the event first shot caused soreness in my arm where the injection was made was recovered on unknown date while for the other event was unknown. No follow up attempts are possible. No further information is expected.

Other Meds: AMLODIPINE; ROSUVASTATIN

Current Illness:

ID: 1384460
Sex: F
Age:
State: TX

Vax Date: 03/09/2021
Onset Date: 03/10/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Global amnesia 24 hrs after the vaccination; This is a spontaneous report from a contactable consumer or other non HCP (patient herself). A 23-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 09Mar2021 (at the age of 23-years-old) as unknown, single dose for covid-19 immunisation. The patient medical history included colitis ulcerative. The patient had covid-19 prior vaccination. The patient had no known allergies. The patient's concomitant medications were not reported. On 10Mar2021, at 07:00 pm, 24 hours after the vaccination the patient experienced global amnesia. The patient was tested for covid post vaccination. The nasal swab was collected, and polymerase chain reaction (PCR) test was done which resulted as negative. The patient did not receive treatment for the event. The outcome of the event was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1384461
Sex: F
Age:
State: CT

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Very mild arm soreness; felt dehydrated; mild headache; fatigue; This is a spontaneous report from a contactable consumer (patient herself). A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EL3247) via an unspecified route of administration, administered in left arm, on 10Mar2021 at 10:45 (at the age of 35 years old) as 1st dose, single dose, for COVID-19 immunization; ethinylestradiol, etonogestrel (ETONOGESTREL/ETHINYLESTRADIOL MYLAN; batch/lot number and dose were not reported) vaginal ring via unspecified route of administration, from unspecified date, at an unknown dose and frequency, for an unspecified indication. The patient's medical history included exercise induced asthma and chronic bronchitis. Concomitant medications were not reported. The patient previously took aspartame and experienced headaches and nausea; and PERCOTCET and experienced vomiting, nausea and hives. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 10Mar2021 at 11:15 A.M., it was reported that the patient experienced very mild arm soreness, felt dehydrated starting about 30 minutes after the vaccine dose through the end of the day, very thirsty despite drinking a lot of water, mild headache and fatigue, moderate in the afternoon and more extreme towards the end of the day. The patient did not receive a treatment for the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The action taken in response to the events for etonogestrel/ ethinylestradiol was unknown. The outcome of the events was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1384462
Sex: F
Age:
State:

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: nausea; stomach pain; dry heaving; feel arm pain and was unable to lift my arm and move it normally; feel arm pain and was unable to lift my arm and move it normally; felt very fatigued and tired; a minor headache; This is a spontaneous report from a non-contactable consumer or other non hcp (patient, self-reporting). A 21-years-old female (non-pregnant) patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number and expiration dates were not reported), via an unspecified route of administration in arm left on 04Mar2021 at 08:00 as 1ST dose, single for COVID-19 immunisation. It was reported that the patient had no allergies, Patient Medical history and concomitant were not reported. The patient did not receive any other vaccine in four weeks and no other medications the patient received within 2 weeks of vaccination. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID. It was reported that on 04Mar2021 at 13:00 several hours after the 1st dose, began to feel arm pain and was unable to lift her arm and move it normally. That evening, felt very fatigued and tired with a minor headache. Exactly 48 hours after the vaccine, she developed nausea and stomach pain that resulted in dry heaving for approximately 3-4 hours. No treatment was received for the events. Facility where the most recent COVID-19 vaccine administered was public health clinic/Veterans Administration facility. On an unspecified date, patient was recovered in the year of 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1384463
Sex: M
Age:
State: NY

Vax Date: 03/07/2021
Onset Date: 03/10/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Sudden worsening on day 4; fever; chills; muscle pain; wheezing; loss of appetite; diarrhea; fatigue; nausea; This is a spontaneous report from a contactable consumer (patient). A 56-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown) via an unspecified route of administration in left arm on 07Mar2021 at 00:30 (age at vaccination 56-year-old) at single dose for covid-19 immunisation. Patient's medical history was not reported. No known allergies were reported. Concomitant medications included clonazepam (KLONOPIN) at 0.5mg, trazodone and diphenhydramine hydrochloride (BENADRYL). Patient did not receive other vaccines in four weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient not tested for COVID-19. On 10Mar2021 at 16:00, patient experienced Sudden worsening on day 4, fever, chills, muscle pain, wheezing, loss of appetite, fatigue, diarrhoea and nausea. No treatment was given for the events. The clinical outcome of the events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds: KLONOPIN; TRAZODONE; BENADRYL

Current Illness:

ID: 1384464
Sex: M
Age:
State:

Vax Date: 02/08/2021
Onset Date: 02/24/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: L sided heart palpitations; This is a spontaneous report from a non-contactable pharmacist. A 84-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9810), via intramuscular on 08Feb2021 (at the age of 84-years-old) as a single dose for covid-19 immunization and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 01Mar2021 (at the age of 84-years-old) as a single dose for covid-19 immunization. It was unknown, whether the patient had other vaccine within four weeks; prior to the vaccination, the patient was diagnosed with COVID-19 or since the vaccination, the patient had been tested for COVID-19. The patient medical history was not reported. Concomitant medication(s) included rivaroxaban (XARELTO); tamsulosin hydrochloride (FLOMAX); metoprolol tartrate; docusate sodium (STOOL SOFTENER); levothyroxine; furosemide; omeprazole; potassium. On 24Feb2021, the patient experienced L sided palpitations after COVID-19 vaccine 08Feb2021. First episode lasted 4-5 hours: Blood pressure -113/78 mmhg, Heart rate- 78, O2 consumption - 96 and oxygen saturation: 96 %. Happened a few hours after second dose of vaccine as well (01MAR2021). The patient visited to doctor or other healthcare professional office/clinic visit for adverse event. He visited PCP and was stable. It was unknown, whether patient recevied any treatment. Outcome of the event was resolved on an unspecified date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds: XARELTO; flomax; METOPROLOL TARTRATE; STOOL SOFTENER; LEVOTHYROXINE; FUROSEMIDE; OMEPRAZOLE; POTASSIUM

Current Illness:

ID: 1384465
Sex: M
Age:
State: MA

Vax Date: 03/04/2021
Onset Date: 03/06/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: 6 years ago I had chip in L elbow, pain. could not bend elbow in comfort, to touch face difficult to dress etc. 2 days after vaccine I had the same thing happen; This is a spontaneous report from a contactable consumer (patient). A 62-years-old male patient received bnt162b2 (Pfizer BioNTech Covid-19 Vaccine, Formulation: Solution for injection, Lot number: EN6206 and Expiration date: unknown), dose 1 via an unknown route of administration in left arm on 04Mar2021 11:45 as single dose for covid-19 immunization at facility. Medical history included Aspirin Reyes syndrome as child. There were no concomitant medications. The patient has not tested positive for covid prior and post vaccination. No other vaccine in four weeks nor Other medications in two weeks. On 06Mar2021 09:00 (2 days after vaccine as reported), the patient experienced the same thing which happened 6 years ago, he had chip in l elbow, pain. could not bend elbow in comfort, to touch face difficult to dress etc. First time in 6 years. Possible coincidence, possible side effect, better: not well yet. It was unknown if patient received treatment. Outcome of event was not recovered. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1384466
Sex: F
Age:
State: WA

Vax Date: 03/05/2021
Onset Date: 03/05/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: left are sore; mild headache; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non pregnant female patient received fist dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6200) via an unspecified route of administration, administered in Arm Left on 05Mar2021 11:45(at the age 0f 34-year-old) as, single for covid-19 immunisation. The patient Medical history included psoriatic arthropathy and had allergies to sulfadrugs from an unknown date and unknown if ongoing. Concomitant medication included etanercept (ENBREL), paracetamol (TYLENOL), omeprazole (OMEPRAZOLE), buprenorphine hydrochloride, naloxone hydrochloride (SUBOXONE), ibuprofen taken for an unspecified indication and received within 2 weeks of vaccination. The patient did not receive any other vaccine within four weeks prior to the vaccine. Prior and since the vaccination the patient was not diagnosed with COVID-19. On 05Mar2021 13:00 the patient experienced left are sore and mild headache. Therapeutic measures were taken as a result of left are sore, mild headache and included treatment with ibuprofen and Tylenol. The outcome of the events was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ENBREL; TYLENOL; OMEPRAZOLE; SUBOXONE; IBUPROFEN

Current Illness:

ID: 1384467
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Sore muscle at injection site; This is a spontaneous report from a non-contactable Consumer or other non HCP (patient, self-reporting). A 36-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number and expiration dates were not reported) via an unspecified route of administration, in left arm on an unspecified date (at the age of 36-years-old) as a single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication(s) included escitalopram oxalate (LEXAPRO) on n unknown date for unknown indication. The patient was not pregnant at the time of vaccination. The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unspecified date, the patient experienced sore muscle at injection site. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: LEXAPRO

Current Illness:

ID: 1384468
Sex: F
Age:
State: MI

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: patient developed a swelling under her lip; t felt like a wad of cotton between her lip and gum; This is a spontaneous report received. A contactable consumer (patient) reported a non-pregnant 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unknown route of administration on 09Mar2021 (batch/lot number: not reported) as 1st dose, single dose for COVID-19 immunisation. Patient's medical history included myocardial bridging (myocardial bridge). Concomitant medications included ranolazine (RANEXA), meloxicam, diltiazem hydrochloride (CARTIA), metoprolol and sertraline for unspecified indications. It was reported that the patient had an allergy to ACE inhibitors. Approximately 3 hours after administration of BNT162B2, the patient developed a swelling under her lip. The patient stated that it felt like a wad of cotton between her lip and gum. She wasn't sure if it was related but she felt it should be reported as it was very strange. The patient visited the physician's office for consultation regarding her condition. She was treated with steroid and diphenhydramine (BENADRYL) shots. The patient was able to recover from the reported event. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: RANEXA; MELOXICAM; CARTIA [DILTIAZEM HYDROCHLORIDE]; METOPROLOL; SERTRALINE

Current Illness:

ID: 1384469
Sex: F
Age:
State: FL

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: really bad metallic taste in her mouth; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number and expiration date unknown), via an unspecified route of administration, administered in the left arm on 09Mar2021, 13:15 (at the age of 36 years old), as first dose, single dose for COVID-19 immunisation. Medical history included bipolar disorder, anxiety disorder, and hepatic adenomatosis. The patient was not pregnant on the time of the report. Concomitant medications included lithium, quetiapine fumarate (SEROQUEL), dicyclomine, fexofenadine hydrochloride (ALLEGRA), alprazolam (XANAX). The patient did not receive other vaccines within four weeks prior to vaccination. The patient had a really bad metallic taste in her mouth starting approximately one hour after vaccination and lasted for 10 hours on 09Mar2021, 14:15. The patient had no COVID prior vaccination and was not COVID tested post-vaccination. No treatment was received for the event. The outcome of the event was recovered on 10Mar2021, 00:15. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LITHIUM; SEROQUEL; DICYCLOMINE; ALLEGRA; XANAX

Current Illness:

ID: 1384470
Sex: F
Age:
State: CA

Vax Date: 03/08/2021
Onset Date: 03/10/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: cheek feels bruised and is very swollen and hurts to touch; cheek feels bruised and is very swollen and hurts to touch; cheek feels bruised and is very swollen and hurts to touch; oozing rash on my chest that burns; This is a spontaneous report from a contactable consumer (patient). A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1, via unspecified route of administration, administered on the left arm on 08Mar2021 (Batch/Lot Number: not reported) as 1st dose, single dose for COVID-19 immunization. The patient's medical history included allergies on peaches and apples and patient had filler in both cheeks and lips. The patient's concomitant medication was not reported. On 10Mar2021, the patient reported that her left cheek felt bruised, very swollen and hurt to touch. The patient had filler in both cheeks and lips and only one cheek was swollen. The patient also reported that she had oozing rash on chest that burns. Treatment received was unknown. The outcome of the events was not recovered. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1384471
Sex: U
Age:
State:

Vax Date: 03/09/2021
Onset Date: 03/10/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: I feel like uncomfortable today; This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received unspecified dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 09Mar2021 as SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. Patient had vaccine yesterday and felt like uncomfortable today. Patient would like to know if can take Advil. The outcome of the events unknown. Limited information available on call. No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1384472
Sex: F
Age:
State: FL

Vax Date: 02/26/2021
Onset Date: 02/28/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: possible Sx of Temporal arteritis; left side only- Tenderness, peri- temporal area; fatigue; Blurry vision; joint pain (bone on bone feeling); This is a spontaneous report from a contactable nurse (patient herself). A 68-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6200, expiration date not reported), via an unspecified route of administration, administered in the left arm on 26Feb2021 11:30 (at the age of 68-years-old) as second dose, single dose for COVID-19 immunisation. Relevant medical history included allergy to NSAIDs, cephalosporin, and bee stings, Epstein-Barr virus infection (EBV), chronic obstructive pulmonary disease (COPD), drug induced immune thrombocytopenia (ITP with NSAIDs and Rebetol/Interferon), "T&A", tubal ligation, cholecystectomy, and osteoporosis. Concomitant medications included Zinc, Vit D3, probiotics, and calcium, all taken for an unspecified indication, start and stop dates were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9262, expiration date not reported), via an unspecified route of administration, administered in the left arm on 05Feb2021 15:30 (at the age of 68-years-old) as first dose, single dose for COVID-19 immunisation. After first dose, on an unspecified date in Feb2021, the patient experienced platelets down to 140k, (Hx of drug induced ITP), and splenic discomfort/pain. Patient also previously received NSAIDs, Interferon and Rebetol and experienced immune thrombocytopenia (drug induced ITP). The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced possible sx of temporal arteritis, left side only- tenderness, peri- temporal area , fatigue, blurry vision, and joint pain (bone on bone feeling) on 28Feb2021 00:00. The patient underwent lab tests and procedures which included platelet count: down to 140k on an unspecified date in Feb2021. Patient waiting on CBC & sediment rate (ESR) bloodwork results. No treatment was received as a result of the events. Patient seek consult of physician as a result of the events. The outcome of all events was not recovered.

Other Meds: ZINC; VIT D3; PROBIOTICS; CALCIUM

Current Illness:

ID: 1384473
Sex: M
Age:
State: MI

Vax Date:
Onset Date:
Rec V Date: 06/09/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: However found out today a friend's brother had the same issue after 1st shot. He also started feeling bad 5 days after 1st shot and broke out with Shingles at 10 days; feeling bad 5 days after 1st shot; This is a spontaneous report from a contactable consumer. This consumer reported for a male patient (friend's brother). A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced shingles. It was reported by the consumer that Reporter found out today a friend's brother had the same issue after 1st shot. he also started feeling bad 5 days after 1st shot and broke out with shingles at 10 days. The outcome of the events were unknown. No follow-up attempts are possible, information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021265079 same reporter/product/event, different patient

Other Meds:

Current Illness:

ID: 1384474
Sex: F
Age:
State: IA

Vax Date: 03/06/2021
Onset Date: 03/08/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Severe stomach cramps; diarrhea; This is a spontaneous report from a contactable other hcp (patient herself). A 31-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6203, expiration date not reported), intramuscularly, administered in the left arm on 06Mar2021 12:30 (at the age of 31-years-old), as first dose, single dose for COVID-19 immunisation. Patient 's medical history was not reported and there were no concomitant medications. The patient was not pregnant at the time of vaccination. Patient has no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient experienced severe stomach cramps and diarrhea on 08Mar2021 00:00. No treatment was received as a result of the events. Patient did not seek consult to physician or urgent care. The outcome of event was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1384475
Sex: F
Age:
State: CA

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Irregular Vaginal bleeding; Nausea; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: ENG206; Expiration date were not reported), via unspecified route of administration in the left arm on 10Mar2021 03:15 PM (at the age of 50-years-old) as second dose, single dose for COVID-19 immunisation at a School or Student Health Clinic. Medical history included asthma and thyroid from an unknown date and unknown if ongoing. The patient was taking other medications in two weeks. The patient previously took Vitamin B12 (reported as B12) and experienced drug allergy. The patient was previously vaccinated with BNT162B2 (Batch/Lot Number: ENG201) in the left arm on 09Feb2021 03:15 PM as first dose, single dose for COVID-19 immunisation. Patient was also previously vaccinated with Tetanus vaccine in the left arm on 20Jan2021 as first dose for tetanus immunization and experienced Shingles. The patient was not pregnant at the time of vaccination. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. On 10Mar2021, the patient experienced irregular vaginal bleeding and nausea. No treatment was given as a result of the events. The outcome of the event was not recovered No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1384476
Sex: F
Age:
State: NY

Vax Date: 03/09/2021
Onset Date: 03/10/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: tingling in finger tips; pain; swelling; fever; chills; tiredness; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 09Mar2021 at 10:00 (Batch/Lot Number: EL3247) (at the age of 51-years-old) as first dose, single dose for COVID-19 immunisation. Medical history included high blood pressure and Covid-19 prior to vaccination. Concomitant medications included amlodipine and carvedilol; both taken for an unspecified indication, start and stop date were not reported. On 10Mar2021 at 08:00, patient experienced tingling in finger tips, pain, swelling, fever, chills, tiredness. Patient did not received any treatment for the events. Patient had not tested for Covid post vaccination. Outcome of the events was recovering. No follow-up attempts needed. No further information expected.

Other Meds: AMLODIPINE; CARVEDILOL

Current Illness:

ID: 1384477
Sex: M
Age:
State: PA

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: minor sore arm; This is a spontaneous report from a contactable consumer. An adult male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 10Mar2021 (Batch/Lot number was not reported) as 1st dose, single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was unknown if there are other vaccine administered in four weeks. There was no COVID prior vaccination, and patient was also not COVID tested post vaccination. The patient experienced minor sore arm on 10Mar2021 with outcome of unknown. It was unknown if there was any treatment for the event. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1384478
Sex: F
Age:
State: CT

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: arm is very sore; This is a spontaneous report from a contactable consumer (patient reporting for herself). A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EL3247) via an unspecified route of administration, administered in left arm, on 10Mar2021 at 09:30 (at the age of 39 years old) as 1st dose, single dose, for COVID-19 immunisation. The patient's medical history was not reported. The patient has no known allergies. The patient was not pregnant at the time of report. Concomitant medications included cyanocobalamin (VIT B12); iron; vitamin b complex (VITAMIN B); magnesium; loratadine (ALAVERT), all were taken for an unspecified indication, start and stop date were not reported, and an over the counter allergy medication. Historical vaccine included flu shot and experienced a very sore arm. The patient has no other vaccine in four weeks. On 10Mar2021 at 09:30 A.M, it was reported that the patient's arm was very sore, and no other sign occurred. She also experienced the same thing when she got the same flu shot every year. The patient did not receive a treatment for the adverse event. The patient had no COVID prior vaccination and she was not tested post-vaccination. No Follow-up attempts are possible: No Further information is excepted.

Other Meds: VIT B12; IRON; VITAMIN B; MAGNESIUM; ALAVERT

Current Illness:

ID: 1384479
Sex: M
Age:
State: CA

Vax Date: 03/11/2021
Onset Date: 03/11/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: "Cut body" (Flu-like symptoms); fever; This is a spontaneous report from a contactable healthcare professional (patient himself). A 37-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 11Mar2021 at 05:00 (Batch/Lot number was not reported) (at the age of 37-years-old) as unknown, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient was not diagnosed with COVID-19 prior to vaccination. Patient did not received any vaccines within 4 weeks prior to Covid vaccine. On 11Mar2021 at 12:15, patient experienced "cut body" (flu-like symptoms) and fever. Since the vaccination, the patient had not been tested for COVID-19. Outcome of events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1384480
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Callers mom received first dose and was diagnosed with shingles a few days later.; This is a spontaneous report from a contactable consumer reporting for Mother via medical information team. A female patient of an unspecified age received BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection; Lot number and Expiration date: Not reported), dose 1 via an unspecified route of administration on an unspecified date as 1st dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Reporter asked whether her mother can get the second dose of the vaccine. After receiving first dose of vaccine, patient was diagnosed with shingles a few days later. The outcome of event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1384481
Sex: M
Age:
State: CT

Vax Date: 02/24/2021
Onset Date: 03/03/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Shingles diagnosis/Rash/Blister; Right ribcage bone and muscle pain; Right ribcage bone and muscle pain; This is a spontaneous report from a contactable consumer or other Non-HCP reported that a male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number and expiration date were unknown), via an unspecified route of administration on 24Feb2021 as a single dose for COVID-19 immunisation. The patients medical history and concomitant medications were not reported. It was unknown if the patient has received any other vaccine in four weeks. The patient experienced Right ribcage bone and muscle pain on 03Mar2021, developed rash on 07Mar2021, blister on 09Mar2021, and on 11Mar2021, diagnosed with Shingles and has been prescribed valacyclovir and naproxen. The adverse events resulted in Doctor or other healthcare professional office/clinic visit and treatment was received. Therapeutic measures were taken for the adverse events which includes Valacyclovir and naproxen. It is unknown if the patient got Covid prior vaccination and unknown if tested for Covid-19 post vaccination. The reporter became aware of the adverse events on 12Mar2021. The outcome of the events was recovering. No follow-up attempts are possible; information about lot/batch number cannot been obtained.

Other Meds:

Current Illness:

ID: 1384482
Sex: F
Age:
State: MA

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: metallic taste in her mouth; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female Patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6198) via an unspecified route of administration on 08Mar2021 (73-year-old at the time of vaccination) as first dose, single dose for COVID-19 immunization. The patient medical history included breast cancer survivor. The patient concomitant medications were not reported. The patient past medication included Tamoxifen and Femara those were pills that she took for 10 years. She took Tamoxifen for 5 years and Femara for 5 years. She remembers the first initial of one of the drugs for the actual chemo, it began with a C if she heard it, she would know it, but she cannot remember it. On 08Mar2021, about 2 hours after receiving the first dose, the patient had a metallic taste in her mouth, which did not last long and went way after she ate food. The patient thought that she had a metallic taste again today but went away. Patient stated that event made her think of her chemotherapy treatment which she went through with breast cancer, and she always had a metallic taste in her mouth. The patient tried to go online to find the fact but could not find anything and was not able to determine whether or not it could happen or if there was anything to be concerned about. The patient confirmed that she was calling to know whether the event was associated with the vaccine. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1384483
Sex: F
Age:
State: WV

Vax Date: 02/05/2021
Onset Date: 02/24/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: The patient has tested covid positive post vaccination; The patient has tested covid positive post vaccination; Shingles; This is a spontaneous report from a contactable (Patient). A 39-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Right on 05Feb2021 (Batch/Lot Number: EL9269) as SINGLE DOSE, dose 2 via an unspecified route of administration, administered in Arm Right on 26Feb2021 (Batch/Lot Number: EN6198) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient did not had covid prior to vaccination. The patient has tested covid positive post vaccination on an unspecified date and shingles on 24Feb2021. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: positive on an unspecified date. The outcome of the events were unknown. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the narrative information provided, there is a reasonable possibility that the reported events COVID-19, Drug Ineffective and Herpes zoster is related to BNT162B2 (COVID-19 mRNA VACCINE). The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1384484
Sex: F
Age:
State: MI

Vax Date:
Onset Date:
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: aches, pains; nausea; lymph node swelling; This is a spontaneous report from a contactable consumer (patient's child). This consumer reported similar events for two patients. This is 1st of two reports. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2nd dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter stated that after the second dose, the patient (reporter's mother) described aches, pains, nausea and lymph node swelling on an unspecified date. On 15Mar2021, the reporter stated that her mother mentioned this to him/her (the reporter) on behalf of herself and his/her father. The outcome of the events was unknown. No follow-up attempts are possible; information about lot or batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021276527 Same reporter/product/event, different patient

Other Meds:

Current Illness:

ID: 1384485
Sex: M
Age:
State: MI

Vax Date:
Onset Date:
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Aches and pains; Nausea; Lymph node swelling; This is a spontaneous report from a contactable consumer (patient's child). This consumer reported similar events for two patients. This is the second of two reports. A male patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number was not reported), via an unspecified route of administration, on an unspecified date, as single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. After the second dose, the patient experienced aches, pains, nausea, and lymph node swelling on an unspecified date after use of product. The outcome of the events was unknown. No follow-up attempts are possible; information about lot or batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021276515 Same reporter, product, and event; different patient

Other Meds:

Current Illness:

ID: 1384486
Sex: F
Age:
State: OH

Vax Date: 02/26/2021
Onset Date:
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: still experiencing ache in her arm/ very sore arm for 2-3 days, very sore arm for 2-3 days, with a dull ache for a week; chills; felt 'achy'; headache; This is a spontaneous report from a contactable consumer (patient) received from a Pfizer-sponsored program. An 81-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number and expiration date not reported), via an unspecified route of administration on 26Feb2021 (at an unspecified age) at 1st dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient reported that she had her first dose of the vaccine last 26Feb2021, and was still experiencing ache in her arm, which started on an unspecified date. On 17Mar2021, it was reported that the patient was scheduled to receive her second dose this Friday, 19Mar2021. On an unspecified date, after her first dose, the patient experienced very sore arm for 2 to 3 days with a dull ache for a week, headache for 24 hours, chills, and the patient felt 'achy'. Outcome of the events pain in arm and headache was recovered on an unspecified date, and for other events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1384487
Sex: F
Age:
State:

Vax Date:
Onset Date: 03/14/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: she attributed to pollen allergy; flu; cough; fever; headache; she is presenting suspected COVID symptoms.; she is presenting suspected COVID symptoms.; This is a spontaneous report from a non-contactable consumer via medical information team. A female patient of an unspecified age received of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: Unknown) via an unspecified route of administration on an unspecified date as 1st dose, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that on 14Mar2021 she had cough and symptoms that she attributed to pollen allergy. She stated that she had headache and fever on 14Mar2021, feeling like she was going through the flu. It was reported that she had her second dose of vaccine scheduled on 25Mar2021 and currently she was presenting suspected COVID symptoms. The events were considered as non-serious by reporter. The events suspected covid and drug ineffective was considered as serious (medical significant). The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1384488
Sex: F
Age:
State: OR

Vax Date: 02/26/2021
Onset Date:
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: developed light case of Shingles; This is a spontaneous report from a contactable other hcp (patient herself). A 68-years-old non-pregnant female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration, administered in left arm on 26Feb2021 16:30 (at the age of 68-year-old non-pregnant) (Lot Number: en6198, Expiration date: unknown) as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included hypothyroid. Concomitant medication included unspecified medication. Patient has not covid-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced developed light case of shingles on an unspecified date. Patient was not tested positive for covid-19 after vaccination. Outcome of event was recovering. No Follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1384489
Sex: F
Age:
State: NJ

Vax Date: 03/03/2021
Onset Date: 03/05/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 03Mar2021 (Batch/Lot number was not reported) as 1st dose, single dose for COVID-19 immunization. Medical history included Lupus. The patient's concomitant medications were not reported. Patient got her first dose of the vaccine last 03Mar2021. She experienced chills, fever and body pain on the second day after the first dose of the vaccine. Now, she feels weak and has no energy. She wanted to know if this was normal. She has a pre-existing condition which was lupus. She was worried that she might get a worse reaction after the second dose. Her second dose was scheduled on 24Mar2021. The outcome of events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1384490
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: I can't smell and still I can't smell today either; This is a spontaneous report from a contactable consumer (patient reported for self). A patient of unspecified age and gender received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EN6499), via an unspecified route of administration on an unspecified date at an unknown, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced I can't smell and still I can't smell today either on an unspecified date. Reporter stated, patient got the Pfizer vaccine on Tuesday and Thursday patient start experiencing, I can't smell and still I can't smell today either so, patient was wondering did the vaccine have anything is this one of the symptom, that's not listed. Outcome of the event was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1384491
Sex: M
Age:
State: SC

Vax Date: 02/14/2021
Onset Date: 03/01/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: shingles; This is a spontaneous report from a contactable physician (patient). A 74-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EN6200), via intramuscular route, administered in left arm on 14Feb2021 at 12:45 as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. The patient's medical history included crohn's disease, reflux gastritis, benign prostatic hyperplasia, arthritis and sulphur allergy. Concomitant medication(s) included mesalazine (PENTASA); Tamsulosin hydrochloride (FLOMAX); finasteride (PROSCAR); esomeprazole sodium (NEXIUM). On 01Mar2021 at 14:00, the patient experienced shingles. The patient received acyclovir as treatment for the adverse event. The patient visited physician's office for the event. The patient was not diagnosed with covid-19 prior vaccination and was not tested post vaccination. There was no other vaccine administered on the same day of the suspect vaccine. The outcome of the event was recovered on an unspecified date of 2021. No follow-up attempts are possible. No further information is expected.

Other Meds: PENTASA; FLOMAX [TAMSULOSIN HYDROCHLORIDE]; PROSCAR; NEXIUM [ESOMEPRAZOLE SODIUM]

Current Illness:

ID: 1384492
Sex: F
Age:
State: MN

Vax Date: 03/03/2021
Onset Date: 03/12/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Blood pressure jumped to 239 over 135; This is a spontaneous report received from a contactable consumer. A 72-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number unknown), via an unspecified route of administration, administered in left arm on 03Mar2021, at 10:30 as single dose for covid-19 immunization when the patient was 72-years-old . Medical history included hypertension from an unknown date. The patient was not pregnant Prior to vaccination, the patient was not diagnosed with COVID-19; since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included metoprolol tartrate (MANUFACTURER UNKNOWN) taken for an unspecified indication, start and stop date were not reported; losartan (MANUFACTURER UNKNOWN) taken for an unspecified indication, start and stop date were not reported; indomethacin sodium (MANUFACTURER UNKNOWN) taken for an unspecified indication, start and stop date were not reported; aspirin (ASPIRIN) taken for an unspecified indication, start and stop date were not reported. The patient experienced blood pressure jumped to 239 over 135 on 12Mar2021, at 14:30. Treatment received for the adverse event included additional amlodipine 10mg tablet given to lower blood pressure. The patient underwent lab tests and procedures which included blood pressure measurement: 239/135 on 12Mar2021 at 3:00 pm. The clinical outcome of blood pressure jumped to 239 over 135 was recovering.

Other Meds: METOPROLOL TARTRATE; LOSARTAN; INDOMETHACIN SODIUM; Aspirin

Current Illness:

ID: 1384493
Sex: F
Age:
State:

Vax Date: 03/04/2021
Onset Date:
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: makes her very moody; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration on 04Mar2021 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for COVID-19 immunisation; and testosterone cipionate (manufacturer unknown), route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication. The patient's medical history and concomitant medications were not reported. The patient received the 1st dose of the vaccine 04Mar2021 and was due for 2nd 25Mar2021. The patient mentioned that her family members tested positive for Covid and she was wondering what kind of protection she had after receiving 1st dose. She was also wondering if she should wait to visit until after 2nd dose. She mentioned that she took testosterone on an unspecified date and it made her very moody on an unspecified date. The outcome of the event was unknown. The action taken in response to the event for testosterone cipionate was unknown. Pfizer is a marketing authorization holder of [TESTOSTERONE CIPIONATE] in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of [TESTOSTERONE CIPIONATE] has submitted the same report to the regulatory authorities. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1384494
Sex: M
Age:
State: CA

Vax Date: 03/09/2021
Onset Date: 03/12/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Shingles after 2nd dose of Pfizer Covid vaccine; This is a spontaneous report from a contactable male consumer (patient). A 54-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for Injection, Lot Number: unknown), via an unspecified route of administration on 09Mar2021 at 13:45 (at the age of 54-year-old) at a 2nd dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient had no known allergies. The patient previously received the first dose of bnt162b2, dose 1 on an unspecified date for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks. The patient did not receive any other medications in 2 weeks. Patient was not diagnosed with COVID-19 prior to vaccination. The patient had not tested COVID-19 post vaccination. The patient experienced shingles after 2nd dose of Pfizer COVID vaccine on 12Mar2021 at 06:00. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient received anti-viral as a treatment medication for the event. The outcome of the event was not resolved. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1384495
Sex: M
Age:
State: NY

Vax Date: 03/10/2021
Onset Date:
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Lost sense of taste of smell; Lost sense of taste of smell; This is a spontaneous report from contactable male consumer reported for himself received from a Pfizer-sponsored program. A male patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 10Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced lost sense of taste of smell. Outcome of the events were unknown. No follow-up attempts are possible; Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1384496
Sex: M
Age:
State: NC

Vax Date: 03/12/2021
Onset Date: 03/13/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Severe headache; Whole body pain; All day Vomiting; Nausea; Muscle Spasms; Intense Chills; fever cycle; Very High blood pressure; This is a spontaneous report from a contactable patient. A 52- year-old male patient received first dose of BNT162B2 (Pfizer BioNTech covid 19 vaccine) (Lot no.: EN6207) via an unspecified route of administration in right arm on 12Mar2021 at 12:00 PM (at the age of 52-years-old) as a single dose for COVID-19 vaccination. Medical history included high blood pressure and thyroid disorder. He also thought he had a false negative covid test in Jul2020, and actually did have covid in Jul2020. The patient did not have any allergies to medications, food and other products. Concomitant medication lexapro, losartan, DIM (as reported, unspecified), retinol (vitamin A), vitamin d and phytomenadione (VITAMIN K), trazadone within 2 weeks of vaccination for an unknown indication. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, patient was not tested positive for COVID-19. On 13Mar2021, patient trip to the emergency room (ER) for severe headache, whole body pain, muscle spasms, intense chills and fever cycle, very high blood pressure, all-day vomiting and nausea. Nothing they tried eased any of the symptoms. There is no amount of ibuprofen or acetaminophen. He threw up nausea medicine. Two doses of morphine at the ER took the pain from a 10 to a 7. He had never, ever felt this badly. The clinical outcome of the events severe headache, body pain, muscle spasms, intense chills, fever, very high blood pressure, vomiting and nausea was not resolved. No follow-up attempts are possible. No further information is expected

Other Meds: LEXAPRO; LOSARTAN; VITAMIN A [RETINOL]; TRAZODONE; VITAMIN K [PHYTOMENADIONE]; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1384497
Sex: F
Age:
State: CA

Vax Date: 03/13/2021
Onset Date: 03/16/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: sore left eye lid/ bump on lid/ irritation in corner of eye; canker sore on left side of tongue; cystic acne on left shoulder; This is a spontaneous report from a contactable consumer or non-HCP. A 34-year-old female patient received BNT162B2 (Pfizer BIONTECH COVID 19 mRNA Vaccine; lot number EN6208 as a second dose administered in arm Left for COVID-19 immunisation on date 13Mar2021 at 12 pm( patient is 34 years of age at the time of vaccination). Medical history was not reported. Concomitant medication was not reported. On 20Feb2021 at 1pm,patient received BNT162B2(Pfizer BIONTECH COVID 19 mRNA Vaccine; lot number EL9264, as 1st dose on left arm. No allergies to medications, food, or other products. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. The patient was not pregnant at the time of vaccination. On 16Mar2021, patient experienced canker sore on left side of tongue, cystic acne on left shoulder and sore left eye lid/ bump on lid/ irritation in corner of eye. No therapeutic measures were taken. The clinical outcome of the events canker sore on left side of tongue, cystic acne on left shoulder and sore left eye lid/ bump on lid/ irritation in corner of eye was not recovered.

Other Meds:

Current Illness:

ID: 1384498
Sex: M
Age:
State: IL

Vax Date: 03/07/2021
Onset Date: 03/01/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Shingles; This is a spontaneous report from a contactable consumer or other non hcp. A 77-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6206, Expiration Date: was not reported), via an unspecified route of administration, administered in Arm Left on 07Mar2021 as a SINGLE DOSE for covid-19 immunization. The patient's medical history included hypertension. The patient previously took diphenhydramine and experienced drug hypersensitivity and first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EM9810, Expiration Date: was not reported), via an unspecified route of administration, administered in Arm Left on 07Fb2021 12:15PM, as a SINGLE DOSE for covid-19 immunization. Concomitant medications included Benazepril, baclofen, Hydrochlorothiazide and cyanocobalamin (B-12). No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. On an unspecified date Mar2021, the patient experienced shingles. No treatment taken for adverse event. The outcome of the event was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: BENAZEPRIL; BACLOFEN; HYDROCHLOROTHIAZIDE; B-12

Current Illness:

ID: 1384499
Sex: F
Age:
State: OK

Vax Date: 03/12/2021
Onset Date: 03/12/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Diarrhea; headache; sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 32-years-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot: EN6206), via an unspecified route of administration in his right arm on 12Mar2021 at 14:15 (at the age of 32-years-old) for COVID-19 immunisation. Medical history included anemia, blood pressure high, obesity and heart murmur. The patient did not have any allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and the patient was not tested for COVID-19 since the vaccination. Concomitant medication included lisinopril (MANUFACTURER UNKNOWN)), amlodipine Besylate (MANUFACTURER UNKNOWN) and escitalopram (MANUFACTURER UNKNOWN) for an unknown indication. On 12Mar2021, the patient experienced diarrhoea, headache and sore arm. Therapeutic measures were not taken for events experienced. The clinical outcome of the diarrhoea, headache and sore arm was recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: AMLODIPINE BESYLATE; ESCITALOPRAM; LISINOPRIL

Current Illness:

ID: 1384500
Sex: F
Age:
State: GA

Vax Date: 03/03/2021
Onset Date: 03/08/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Lymph node swelling in neck on left side.; This is a spontaneous report from a contactable nurse. A 34-year-old non-pregnant female patient received her dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an intramuscular route of administration in the left arm on 03Mar2021 at 12:30 pm (at the age of 34-year-old at vaccination) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not have any allergies to food, drug or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient did not receive any other medications within two weeks prior to the COVID vaccine. On 08Mar2021, the patient experienced lymph node swelling in neck on left side. Patient did not receive any treatment for the event. The clinical outcome of the event lymph node swelling in neck on left side was not resolved at the time of reporting. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1384501
Sex: F
Age:
State: CO

Vax Date: 03/06/2021
Onset Date: 03/07/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Stomach crampy; Tingling sensations in feet and hands; Sharp pain on the right side of chest; Burning sensations in feet and hands; sore legs; Sore arm; Body aches; Chills; Slight fever; This is spontaneous report from a contactable patient. A 31-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199), via an unspecified route of administration in the right arm on 06Mar2021 at 15:00, (at the age of 31-years-old) as a single dose for COVID-19 immunization. It was unknown whether the patient was pregnant at the time of vaccination. Medical history included sinusitis, asthma, gastroesophageal reflux disease (GERD), allergy to penicillin and shellfish. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included Symbicort , Budesonide (sinus rinse) (MANUFACUTRER UNKNOWN) and Azelastine (MANUFACUTRER UNKNOWN), all for unknown indication from an unknown date. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201), via an unspecified route of administration in the right arm on 11Feb2021 at 14:30 (at the age of 31-years-old) as a single dose for COVID-19 immunization. The patient didn't received any other vaccines within 4 weeks prior to the COVID-19 vaccination. On 15Mar2021, the patient had a nasal swab (Covid antigen) test and the test result was negative. On 07Mar2021, the patient experienced normal side effects such as sore arm, slight fever, chills and body aches and was fine after that. On 14Mar2021 at 12:00, the patient experienced tingling and burning sensations in feet and hands, legs were very sore like she had done a difficult work out which was actually not done and also had a sharp pain on the right side of chest and stomach was crampy. It was unknown whether the patient received any treatment for the events. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events sore arm, slight fever, chills and body aches was resolved. The clinical outcome of the events sharp pain on the right side of chest, burning sensations in feet and hands, stomach crampy, tingling sensations in feet and hands and sore legs was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: AZELASTINE; Symbacort; BUDESONIDE

Current Illness:

ID: 1384502
Sex: F
Age:
State:

Vax Date: 09/09/2020
Onset Date:
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Severe body aches in all joints; This is a spontaneous report from a contactable healthcare professional from a Pfizer-sponsored program. A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as 1st dose, single for COVID-19 immunization; and tofacitinib citrate (XELJANZ XR, 11 mg Prolonged-release tablet), oral from 09Sep2020 and ongoing, at 11 mg, 1x/day for rheumatoid arthritis. Medical history and concomitant medications were not reported. The patient experienced severe body aches in all joints on an unspecified date, which lasted a few days and resolved. The action taken in response to the event for tofacitinib citrate was unknown. The outcome of the event was resolved on an unspecified date. No follow-up attempts are possible. Information about batch/lot number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1384503
Sex: F
Age:
State:

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Tingling tongue; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: Ep6955), via an unspecified route of administration in right arm on 07Jan2021 at 08:00 as a single dose (at the age of 33 years old) for COVID-19 immunisation. Medical history included asthma, recurrent pneumonia, chronic sinusitis, birch pollen allergy, some nuts allergy, and dust allergy. Concomitant medication was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, and medications within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient received treatment with BENADRYL for the reported event. On 07Jan2021 at 08:45, tingling tongue. The clinical outcome of event tingling tongue was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness: Allergy to nuts; Birch pollen allergy; Dust allergy

ID: 1384504
Sex: F
Age:
State: IN

Vax Date: 03/16/2021
Onset Date: 03/16/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: problems with her breathing; itching in her mouth and all over; itching in her mouth and all over; fine rash on her upper body; Itching; Wheezing; I feel like I have ticks and fleas all over me.; Cough; This is a spontaneous report from a contactable consumer and nurse (patient) via Medical information team. A 67-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6208, Expiration date was not reported), via intramuscular in left arm on 16Mar2021 13:20 as single dose for covid-19 immunisation. Medical history included allergies to seafood, peanuts allergy, ongoing lupus, ongoing Sjogren's syndrome, asthma (Diagnosed many years ago. States it was well controlled until she had the Covid Vaccine), ongoing blood pressure high (diagnosed a long time ago; maybe in 1992), ongoing seizures (States they are well controlled and her last one was 10 years ago), restless legs and food and drug allergies. Concomitant medications included fluticasone propionate, salmeterol xinafoate (ADVAIR) via unspecified route from unspecified date and ongoing at 550, two times a day for asthma, salbutamol (ALBUTEROL HFA) via unspecified route from unspecified date and ongoing at 3-4 times a day for asthma, metoprolol via unspecified route from unspecified date and ongoing at 25 mg, two times a day for hypertension, levetiracetam (KEPPRA) via unspecified route from unspecified date and ongoing at 500 mg, twice a day for seizure, diltiazem via unspecified route from unspecified date and ongoing for hypertension, clonazepam (KLONOPIN) via unspecified route from unspecified date and ongoing at 50 mg for seizures, epinephrine (EPIPEN) via unspecified route from unspecified date and ongoing for drug and food allergy and topiramate (TOPAMAX) via unspecified route from unspecified date and ongoing at 50 mg, two times a day for seizures. Patient received her first dose of the Pfizer COVID-19 vaccine. patient first had a problem with her breathing. Within a few minutes, she had itching in her mouth and all over. She had a fine rash on her upper body. She was itching and wheezing. The doctor administered the EpiPen she carries in her left thigh. 911 was also called to take her to the hospital. She was also given 50mg orally of Benadryl. She was taken to the ER and administered 2 different IV medications. She mentions she was given an IV push of salmeterol; it was like Pepcid. She clarifies further it was like a form of prednisone. She was also something else IV but she doesn't know the name of it. The caller confirms she has no NDC, Lot number or expiry date for these medications she was given at the ER and/or vaccination facility site. The caller states she is still having problems with itching. She is still really itchy. She asks, when will this stuff clear out of her system. She has been taking Benadryl to calm down. She was given the COVID-19 vaccine through her arm, so it was in her system, but the itching is still here today. She is constantly scratching. She took Benadryl and used her rescue inhaler. She has her inhaler, but she keeps itching. She clarifies her rescue inhaler is Xopenex HFA (Lot number: 180456). She is prescribed to take 2 puffs every 6 hours as needed. When probed for the Benadryl she is currently taking, she clarifies it is Equate dye-free allergy relief, 25mg (Lot number: P11756, Expiry date: Oct2021). patient states she is still itching and she "feels like there are ticks and fleas all over me". patient wants to know how long to expect the itching to last? patient also stated she would not be getting the second dose. Patient reportedly received her covid vaccine and 20 minutes after experienced shortness of breath, cough, wheezing, rash and itching which is still ongoing 1 month later. The consumer further stated that she still has itching on her arms and back. HCP and the safety team is authorized to contact the HCP. Atarax, strength unknown, was prescribed for treatment of the adverse events. The outcome of the event feeling abnormal, itching all over, Itching mouth was unknown while remaining events was not recovered.

Other Meds: ADVAIR; ALBUTEROL HFA; METOPROLOL; KEPPRA; DILTIAZEM; KLONOPIN; EPIPEN; TOPAMAX

Current Illness: Blood pressure high; Lupus erythematosus systemic; Seizures; Sjogren's syndrome

ID: 1384505
Sex: F
Age:
State: WY

Vax Date: 03/06/2021
Onset Date: 03/06/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: metallic taste; back ache; Neck & back ache; sore arm 3 hours after injection; tingling skin; racing heart; sore throat; high blood pressure; lower lip swelling; hives; This is a spontaneous report from a contactable consumer (patient). A 69-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration in the arm right on 06Mar2021 at 13:00 (at the age of 69-years-old), as a single dose for COVID-19 immunisation at Public Health Clinic/Veterans Administration facility. The medical history includes type 1 diabetes, thyroid disease, colitis, lichen sclerosis, carpel tunnel syndrome, legionnaire's disease, mixed hyperlipidemia and hx of Cdiff. Patient was allergic to PCN (penicillin), sulfa, IV iodine, codeine, blue cheese and adhesive bandage. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination she was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. Concomitant medications included insulin aspart (NOVOLOG), insulin glargine (BASAGLAR), gabapentin (MANUFACTURER UNKNOWN), ibandronate sodium (BONIVA) and levothyroxine sodium (SYNTHROID). On 06Mar2021, the patient developed lower lip swelling, tingling, hives and sore arms three hours after the vaccination, tingling skin, sore throat, high blood pressure and racing heart. On the same day (06Mar2021), the patient had visited the OPD clinic and was prescribed diphenhydramine hydrochloride (BENADRYL). On 13Mar2021, the symptoms had returned with metallic taste, swelling lip, neck & back ache and went to ER (emergency room) where patient was prescribed with famotidine (MANUFACTURER UNKNOWN) and can use diphenhydramine hydrochloride (BENADRYL). On 16Mar2021, the patient met the physician and was prescribed fexofenadine hydrochloride (ALLEGRA) and montelukast (MANUFACTURER UNKNOWN) as the symptoms were the same. The adverse event result in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Treatment was received for the adverse events, including Benadryl/Famotidine/Allegra/montelucast. The clinical outcome of all the events was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: BONIVA; BASAGLAR; NOVOLOG; SYNTHROID; GABAPENTIN

Current Illness:

ID: 1384506
Sex: F
Age:
State: MD

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 06/09/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Flushed face; face twitching; Light headedness; This is a spontaneous report received from a contactable healthcare professional. A 43-year-old, non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration in the left arm on 17Mar2021 at 15:00 PM (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included Diabetes Type 2 from an unknown date. The patient reported being allergic to Penicillin and Sulpha. Patient had no symptoms associated with COVID-19 and not had a COVID-19 test. On 17Mar2021 at 15:00 PM, the patient experienced flushed face after the vaccine was administered. He also felt both sides of the face being twitched and light headedness. The patient did not receive any treatment for flushed face, twitched face and light headedness. The clinical outcome of flushed face, twitched face and light headedness were reported as not recovered. Information about Lot number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm